DEVELOPMENT OF A NEW SCORE PREDICTIVE OF SUSTAINED CLINICAL REMISSION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE UNDER INFLIXIMAB-AZATHIOPRINE COMBOTHERAPY.

Baptiste Sivard  1     Nicolas Williet  2     Jean-Marc Phelip  2     Emilie Del Tedesco  2     St├ęphane Paul  3     Xavier Roblin    
1 university hospital of Saint-Etiennne,Hepato-gastroenterology,Saint-Priest en Jarez,France
2 University Hospital of Saint-Etienne,Dr.,Saint-Priest en Jarez,France
3 University Hospital of Saint-Eti

Conference
25th UEG Week 2017

Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing